Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2023 · 55 positions · Total reported value $1.44B · Top-10 concentration 59.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, Sofinnova Investments, Inc. disclosed 55 equity positions with a combined reported value of $1.44B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were KRTX ($233.54M), NTRA ($137.20M), AZN ($92.29M). By sector, the heaviest allocations are Health Care 63.9%, Consumer Discretionary 2.5%.

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions.

The largest new positions opened in Q3 2023 were KRTX ($233.54M), NTRA ($137.20M), AZN ($92.29M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • KRTX KARUNA THERAPEUTICS INC · $233.54M
  • NTRA NATERA INC · $137.20M
  • AZN ASTRAZENECA PLC · $92.29M
  • MRK MERCK & CO. INC. · $74.99M
  • ASND ASCENDIS PHARMA A/S · $70.61M
  • RYZB RAYZEBIO INC · $53.71M
  • DXCM DEXCOM INC · $51.33M
  • AVTE AEROVATE THERAPEUTICS INC · $51.01M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 63.9%
Other 33.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.38M $233.54M 16.18%
16.18%
New
2 3.10M $137.20M 9.51%
9.51%
New
3 1.36M $92.29M 6.39%
6.39%
New
4 728.40K $74.99M 5.20%
5.20%
New
5 754.03K $70.61M 4.89%
4.89%
New
6 2.42M $53.71M 3.72%
3.72%
New
7 550.20K $51.33M 3.56%
3.56%
New
8 3.76M $51.01M 3.53%
3.53%
New
9 173.28K $50.65M 3.51%
3.51%
New
10 3.47M $47.53M 3.29%
3.29%
New
11 3.61M $40.58M 2.81%
2.81%
New
12 225.00K $39.77M 2.75%
2.75%
New
13 78.19K $38.44M 2.66%
2.66%
New
14 3.25M $37.65M 2.61%
2.61%
New
15 695.38K $37.30M 2.58%
2.58%
New
16 1.80M $36.19M 2.51%
2.51%
New
17 77.88K $34.06M 2.36%
2.36%
New
18 2.05M $32.46M 2.25%
2.25%
New
19 1.04M $27.98M 1.94%
1.94%
New
20 1.21M $24.31M 1.68%
1.68%
New
21 50.00K $21.37M 1.48%
1.48%
New
22 830.76K $18.15M 1.26%
1.26%
New
23 4.28M $17.98M 1.25%
1.25%
New
24 50.00K $17.91M 1.24%
1.24%
New
25 292.81K $16.69M 1.16%
1.16%
New
26 537.46K $15.05M 1.04%
1.04%
New
27 500.00K $14.73M 1.02%
1.02%
New
28 743.29K $13.64M 0.94%
0.94%
New
29 2.19M $11.96M 0.83%
0.83%
New
30 202.12K $10.19M 0.71%
0.71%
New
31 200.00K $9.08M 0.63%
0.63%
New
32 3.70M $7.85M 0.54%
0.54%
New
33 450.00K $6.53M 0.45%
0.45%
New
34 51.10K $6.19M 0.43%
0.43%
New
35 685.13K $6.14M 0.42%
0.42%
New
36 80.37K $5.62M 0.39%
0.39%
New
37 200.00K $5.50M 0.38%
0.38%
New
38 139.88K $5.37M 0.37%
0.37%
New
39 250.00K $4.28M 0.30%
0.30%
New
40 2.67M $3.45M 0.24%
0.24%
New
41 2.75M $2.86M 0.20%
0.20%
New
42 320.60K $2.58M 0.18%
0.18%
New
43 1.60M $1.81M 0.12%
0.12%
New
44 2.40M $1.46M 0.10%
0.10%
New
45 318.90K $1.13M 0.08%
0.08%
New
46 3.28K $896.05K 0.06%
0.06%
New
47 142.63K $720.31K 0.05%
0.05%
New
48 157.91K $596.89K 0.04%
0.04%
New
49 3.08M $539.96K 0.04%
0.04%
New
50 115.71K $501.03K 0.04%
0.04%
New

FAQ

What did Sofinnova Investments, Inc. buy in 2023-Q3?

In its 2023-Q3 13F filing, Sofinnova Investments, Inc. reported 55 equity positions worth $1.44B in aggregate; its largest disclosed positions were KRTX ($233.54M), NTRA ($137.20M), AZN ($92.29M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.44B of long equity holdings across 55 positions as of 2023-Q3. Top-10 holdings account for 59.8% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →